Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
Altaca
G
G
Haydarpasa Numune Research and Teaching Hospital, Department of Transplantation, Istanbul, Turkey.
Berber
I
I
Aydin
C
C
Yigit
B
B
Aydin
M
M
Titiz
I
I
D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid